Wise Medical Aims to Create New Growth Drivers Through Acquisition of Kereida Laser

China Securities News (reported by Ni Ming) — VISHEE disclosed an institutional research announcement on the evening of December 2. In response to investor questions, the company stated that VISHEE and Coretronic Laser have synergy in customer resources and technology research and development. Through this equity acquisition, it will help strengthen the coverage and extension of the company's original business in departments such as urology and dermatology, bringing reliable opportunities for new department expansion, creating new business growth points, and enhancing profitability. On the other hand, Coretronic Laser’s rich management experience and technical R&D accumulation in the medical laser field will help enhance the company’s independent R&D capabilities in laser technology, promote the development and iteration of the company’s laser energy platform, and continuously improve the quality and performance of existing laser-related products under development. This aligns with the company’s long-term development plan and has a positive impact on operational management.

According to reports, the announcement disclosed by the company in November regarding the acquisition of medical device registration certificates mainly involves the second-generation transcranial magnetic stimulator and the X-locom200 bedside active-passive rehabilitation training system. The acquisition of these two medical device registration certificates will help further expand and improve the company's product layout in the fields of magnetic stimulation and movement rehabilitation, continuously meet diversified market demands, and enhance the company’s overall competitiveness in the field of rehabilitation medicine.